Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT06567769
Eligibility Criteria:
Inclusion Criteria:
* Participants with documented MPS IIIA diagnosis
* Participants aged ≥ 12 months and ≤ 18 years
Exclusion Criteria:
* Participants with significant non-MPS IIIA related central nervous system impairment
* Participants with previous complication from intraventricular drug administration
* Participants with contraindications for MRI scans and for neurosurgery
* Participants that received treatment with any investigational drug or a device intended as a treatment for MPS IIIA within 30 days or 5 half-lives prior to the study
* Participants that received a hematopoietic stem cell or bone marrow transplant or received gene therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
18 Years
Study:
NCT06567769
Study Brief:
Protocol Section:
NCT06567769